These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 12704598

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors.
    Zeltser D, Justo D, Halkin A, Prokhorov V, Heller K, Viskin S.
    Medicine (Baltimore); 2003 Jul; 82(4):282-90. PubMed ID: 12861106
    [Abstract] [Full Text] [Related]

  • 3. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P, Hreiche R, Turgeon J.
    Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature.
    Lawrence KR, Nasraway SA.
    Pharmacotherapy; 1997 Aug; 17(3):531-7. PubMed ID: 9165555
    [Abstract] [Full Text] [Related]

  • 7. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].
    Calderone V, Cavero I.
    Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Drug-induced long QT and torsade de pointes: recent advances.
    Kannankeril PJ, Roden DM.
    Curr Opin Cardiol; 2007 Jan; 22(1):39-43. PubMed ID: 17143043
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
    Sala M, Coppa F, Cappucciati C, Brambilla P, d'Allio G, Caverzasi E, Barale F, De Ferrari GM.
    Curr Opin Investig Drugs; 2006 Mar; 7(3):256-63. PubMed ID: 16555686
    [Abstract] [Full Text] [Related]

  • 20. [Side effects, unwanted drug interactions and the problem of cardiotoxicity].
    Woroń J, Trabka-Janik E, Kostka-Trabka E.
    Przegl Lek; 2003 Mar; 60(4):196-8. PubMed ID: 14569882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.